Maine Protects Cannabis Users from Employment Discrimination | CashCropToday
0 Shares 298 Views

Maine Protects Cannabis Users from Employment Discrimination

March 25, 2018
298 Views

Employee’s working in the state of Main can no longer worry about being drugs tested and disciplined for their off work hours cannabis use. The Main Department of Labor has removed THC from the list of substances that employers are allowed to test for.

Though this move seems progressive, its shocking that other medical and recreational states such as Colorado, California, or Washington state haven’t follow suite. After all why should you be fired for something that is considered legal to consume according to your states government.

This new bill will prohibit employers from refusing to hire or from disciplining anyone over 21 years old that choses to consume marijuana outside of work but, also allows them to ban marijuana from the work place. It also, provided guidelines for discipline of anyone appeared to be “high” during the work day.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
188 views
Global
188 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
186 views
Manufacturing
186 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: